AR045996A1 - Formulaciones semi-solidas para la administracion oral de taxoides - Google Patents

Formulaciones semi-solidas para la administracion oral de taxoides

Info

Publication number: AR045996A1
Authority: AR; Argentina
Prior art keywords: semi; taxoids; oral administration; solid formulations; mixture
Prior art date: 2003-07-18

Application number

ARP040102493A

Other languages

English (en)

Spanish (es)

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-18

Filing date

2004-07-15

Publication date

2005-11-23

2004-07-15 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2005-11-23 Publication of AR045996A1 publication Critical patent/AR045996A1/es

Links

239000000203 mixture Substances 0.000 title abstract 5
239000007787 solid Substances 0.000 title abstract 2
238000009472 formulation Methods 0.000 abstract 2
AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 abstract 1
239000000654 additive Substances 0.000 abstract 1
238000010438 heat treatment Methods 0.000 abstract 1
239000008240 homogeneous mixture Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
239000012439 solid excipient Substances 0.000 abstract 1
238000003756 stirring Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ARP040102493A 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides AR045996A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03291795A EP1498120A1 (en)	2003-07-18	2003-07-18	Semi-solid formulations for the oral administration of taxoids

Publications (1)

Publication Number	Publication Date
AR045996A1 true AR045996A1 (es)	2005-11-23

Family

ID=33462258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP040102493A AR045996A1 (es)	2003-07-18	2004-07-15	Formulaciones semi-solidas para la administracion oral de taxoides

Country Status (20)

Country	Link
US (1)	US20050070496A1 (2)
EP (2)	EP1498120A1 (2)
JP (1)	JP5116306B2 (2)
KR (1)	KR101143341B1 (2)
CN (1)	CN1826110B (2)
AR (1)	AR045996A1 (2)
AT (1)	ATE388701T1 (2)
AU (1)	AU2004262496B2 (2)
BR (1)	BRPI0412759A (2)
CA (1)	CA2532667A1 (2)
DE (1)	DE602004012413T2 (2)
DK (1)	DK1648440T3 (2)
ES (1)	ES2303642T3 (2)
IL (1)	IL173110A (2)
IN (1)	IN229997B (2)
MX (1)	MX260260B (2)
MY (1)	MY137965A (2)
PT (1)	PT1648440E (2)
TW (1)	TWI342774B (2)
WO (1)	WO2005013968A1 (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1498143A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
US20080045589A1 (en) *	2006-05-26	2008-02-21	Susan Kelley	Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
FR2922107B1 (fr) *	2007-10-10	2010-02-26	Aventis Pharma Sa	Nouvelles compositions a base de taxoides
FR2924024B1 (fr)	2007-11-27	2012-08-17	Centre Nat Rech Scient	Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
FR2931152B1 (fr) *	2008-05-16	2010-07-30	Centre Nat Rech Scient	Nouveau systeme de transfert d'acide nucleique
CN102770131A (zh)	2009-10-29	2012-11-07	安万特医药股份有限公司	卡巴他赛的新颖抗肿瘤用途
EA027666B1 (ru)	2010-05-03	2017-08-31	ТЕИКОКУ ФАРМА ЮСЭй, ИНК.	Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
JO3685B1 (ar)	2012-10-01	2020-08-27	Teikoku Pharma Usa Inc	صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103980232A (zh) *	2014-06-05	2014-08-13	北京诺普德医药科技有限公司	10-乙酰基多西紫杉醇及其用途
KR101542364B1 (ko) *	2014-10-31	2015-08-07	대화제약 주식회사	탁산을 포함하는 경구 투여용 약학 조성물
CN113698369A (zh) *	2021-08-31	2021-11-26	无锡紫杉药业有限公司	一种除去卡巴他赛中特定单杂的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3406497A1 (de) *	1984-02-23	1985-09-05	Mueller Bernhard Willi Werner	Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5272171A (en) *	1992-02-13	1993-12-21	Bristol-Myers Squibb Company	Phosphonooxy and carbonate derivatives of taxol
US5254580A (en) *	1993-01-19	1993-10-19	Bristol-Myers Squibb Company	7,8-cyclopropataxanes
US5294637A (en) *	1992-07-01	1994-03-15	Bristol-Myers Squibb Company	Fluoro taxols
JP3208517B2 (ja) *	1992-07-01	2001-09-17	ブリストル−マイヤーズスクイブカンパニー	７，８−シクロプロパタキサン類
US5478854A (en) *	1992-10-01	1995-12-26	Bristol-Myers Squibb Company	Deoxy taxols
US5973160A (en) *	1992-12-23	1999-10-26	Poss; Michael A.	Methods for the preparation of novel sidechain-bearing taxanes
US5646176A (en) *	1992-12-24	1997-07-08	Bristol-Myers Squibb Company	Phosphonooxymethyl ethers of taxane derivatives
US6054136A (en) *	1993-09-30	2000-04-25	Gattefosse S.A.	Orally administrable composition capable of providing enhanced bioavailability when ingested
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
IL131217A0 (en) *	1998-03-10	2001-01-28	Napro Biotherapeutics Inc	Novel methods and compositions for delivery of taxanes
KR100661879B1 (ko) *	1998-04-01	2006-12-27	스키에파마 캐나다 인코포레이티드	항암 조성물
MXPA01011981A (es) *	1999-05-24	2003-09-04	Sonus Pharma Inc	Vehiculo de emulsion para farmacos poco solubles.
US6136846A (en) *	1999-10-25	2000-10-24	Supergen, Inc.	Formulation for paclitaxel
WO2002064132A2 (en) *	2001-01-18	2002-08-22	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US20040092428A1 (en) *	2001-11-27	2004-05-13	Hongming Chen	Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
CA2470826A1 (en) *	2001-12-20	2003-07-03	Bristol-Myers Squibb Company	Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
ES2283756T3 (es) *	2002-03-01	2007-11-01	Novagali Pharma Sa	Sistemas autoemulsionantes de administracion de farmaco para taxoides.
KR20090072980A (ko) *	2007-12-28	2009-07-02	서울옵토디바이스주식회사	발광 다이오드 및 그 제조방법

2003
- 2003-07-18 EP EP03291795A patent/EP1498120A1/en not_active Ceased
2004
- 2004-07-15 MX MXPA06000636 patent/MX260260B/es active IP Right Grant
- 2004-07-15 AR ARP040102493A patent/AR045996A1/es not_active Application Discontinuation
- 2004-07-15 KR KR1020067001136A patent/KR101143341B1/ko not_active Expired - Fee Related
- 2004-07-15 CA CA002532667A patent/CA2532667A1/en not_active Abandoned
- 2004-07-15 AT AT04741331T patent/ATE388701T1/de not_active IP Right Cessation
- 2004-07-15 PT PT04741331T patent/PT1648440E/pt unknown
- 2004-07-15 BR BRPI0412759-5A patent/BRPI0412759A/pt not_active IP Right Cessation
- 2004-07-15 EP EP04741331A patent/EP1648440B1/en not_active Expired - Lifetime
- 2004-07-15 AU AU2004262496A patent/AU2004262496B2/en not_active Ceased
- 2004-07-15 WO PCT/EP2004/008551 patent/WO2005013968A1/en not_active Ceased
- 2004-07-15 DE DE602004012413T patent/DE602004012413T2/de not_active Expired - Lifetime
- 2004-07-15 IN IN198CH2006 patent/IN229997B/en unknown
- 2004-07-15 CN CN2004800207228A patent/CN1826110B/zh not_active Expired - Fee Related
- 2004-07-15 JP JP2006519899A patent/JP5116306B2/ja not_active Expired - Fee Related
- 2004-07-15 DK DK04741331T patent/DK1648440T3/da active
- 2004-07-15 ES ES04741331T patent/ES2303642T3/es not_active Expired - Lifetime
- 2004-07-16 MY MYPI20042868A patent/MY137965A/en unknown
- 2004-07-16 TW TW093121233A patent/TWI342774B/zh not_active IP Right Cessation
- 2004-07-19 US US10/894,163 patent/US20050070496A1/en not_active Abandoned
2006
- 2006-01-12 IL IL173110A patent/IL173110A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP2009513558A (ja)	2009-04-02
CN1826110A (zh)	2006-08-30
KR101143341B1 (ko)	2012-05-24
CN1826110B (zh)	2010-05-12
CA2532667A1 (en)	2005-02-17
HK1091743A1 (zh)	2007-01-26
IN229997B (2)	2009-03-27
EP1648440B1 (en)	2008-03-12
MXPA06000636A (es)	2006-04-19
US20050070496A1 (en)	2005-03-31
DK1648440T3 (da)	2008-07-14
TW200517104A (en)	2005-06-01
AU2004262496B2 (en)	2009-02-05
PT1648440E (pt)	2008-06-24
EP1498120A1 (en)	2005-01-19
TWI342774B (en)	2011-06-01
WO2005013968A1 (en)	2005-02-17
IL173110A (en)	2011-04-28
JP5116306B2 (ja)	2013-01-09
IL173110A0 (en)	2006-06-11
DE602004012413T2 (de)	2009-03-12
DE602004012413D1 (de)	2008-04-24
AU2004262496A1 (en)	2005-02-17
IN2006CH00198A (2)	2007-06-08
ES2303642T3 (es)	2008-08-16
KR20060037370A (ko)	2006-05-03
ATE388701T1 (de)	2008-03-15
BRPI0412759A (pt)	2006-09-26
MY137965A (en)	2009-04-30
EP1648440A1 (en)	2006-04-26
MX260260B (es)	2008-09-04

Similar Documents

Publication	Publication Date	Title
MX2022002548A (es)	2022-03-22	Composiciones medicinales estables de cannabidiol.
AR045996A1 (es)	2005-11-23	Formulaciones semi-solidas para la administracion oral de taxoides
HN2010002735A (es)	2014-07-31	Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidrobenzo(1,4)dioxin-2-ilmetil)-sulfamida
ES2167061T3 (es)	2002-05-01	Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
MX2008009358A (es)	2008-09-10	Una formulacion farmaceutica de taxano, una composicion solida de taxano, un procedimiento para la preparacion de dicha composicion solida de taxano, una composicion solubllizante de dicha composicion solida de taxano, y un conjunto de elementos (kit
MXPA03000065A (es)	2004-04-02	Composiciones de micelas polimericas.
ES2099094T3 (es)	1997-05-16	Metodos y composiciones para tratamiento de interacciones hidrofobas patologicas en fluidos biologicos.
ES2190472T3 (es)	2003-08-01	Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
ES2161085T3 (es)	2001-11-16	Formulaciones que contienen oxaliplatino.
AR005703A1 (es)	1999-07-14	Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
BRPI0409133A (pt)	2006-05-02	formulações farmacêuticas contendo metilnaltrexona
AR049985A1 (es)	2006-09-20	Tratamiento de combinacion para enfermedades malignas no hematologicas
UY28862A1 (es)	2005-11-30	Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
AR020001A1 (es)	2002-03-27	COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
PT1187629E (pt)	2005-02-28	Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
ECSP078023A (es)	2008-01-23	Ingrediente farmacéutico activo en base a canabinoide
SG158870A1 (en)	2010-02-26	Bendamustine pharmaceutical compositions for lyophilisation
NO20060977L (no)	2006-05-19	Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
AR024998A1 (es)	2002-11-06	Nuevos retinoides para el tratamiento del enfisema
AR122059A1 (es)	2022-08-10	Usos y formulaciones de cannabinoides
UY28536A1 (es)	2005-04-29	Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
AR032138A1 (es)	2003-10-29	Derivados de 6-hidroxi-indazol, una composicion oftalmica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de glaucoma
AR118823A1 (es)	2021-11-03	Uso de cannabidiol en el tratamiento del complejo de esclerosis tuberosa
MX2024003093A (es)	2024-04-08	Administracion facilitada de formulaciones concentradas de anticuerpos mediante el uso de hialuronidasa.
PE20211198A1 (es)	2021-07-01	Metodos y formulaciones para tratar nauseas y vomitos inducidos por quimioterapia

Legal Events

Date	Code	Title	Description
2014-12-03	FA	Abandonment or withdrawal
2016-05-31	FB	Suspension of granting procedure